GSA CAPITAL PARTNERS LLP - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 271 filers reported holding HAEMONETICS CORP in Q3 2022. The put-call ratio across all filers is 1.37 and the average weighting 0.1%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q2 2022$1,904,000
+568.1%
29,214
+795.3%
0.29%
+495.8%
Q3 2020$285,000
-2.1%
3,263
+29.0%
0.05%
+41.2%
Q4 2019$291,000
-26.7%
2,529
-19.6%
0.03%
-37.0%
Q3 2019$397,000
-48.8%
3,147
-64.5%
0.05%
-31.6%
Q1 2019$775,000
-47.5%
8,856
-39.9%
0.08%
-53.5%
Q4 2018$1,475,000
-20.1%
14,745
-8.5%
0.17%
+66.7%
Q3 2018$1,846,000
-65.1%
16,107
-72.7%
0.10%
-61.1%
Q2 2018$5,286,000
+518.2%
58,941
+404.3%
0.26%
+482.2%
Q1 2018$855,000
-56.9%
11,687
-73.6%
0.04%
-66.7%
Q3 2017$1,984,000
+442.1%
44,210
+377.6%
0.14%
+462.5%
Q2 2017$366,000
-34.5%
9,257
-46.6%
0.02%
-11.1%
Q4 2015$559,000
-25.6%
17,326
-25.4%
0.03%
-27.0%
Q3 2015$751,000
+2.9%
23,225
+31.6%
0.04%
+32.1%
Q2 2015$730,000
+3.4%
17,654
+12.3%
0.03%0.0%
Q1 2015$706,000
+168.4%
15,726
+123.8%
0.03%
+55.6%
Q4 2014$263,0007,0260.02%
Other shareholders
HAEMONETICS CORP shareholders Q3 2022
NameSharesValueWeighting ↓
Millrace Asset Group, Inc. 19,264$1,7262.13%
Parkman Healthcare Partners LLC 88,962$7,969,2161.46%
HEARTLAND ADVISORS INC 256,414$24,435,2741.37%
Riverwater Partners LLC 15,553$1,393,2381.27%
KINGDON CAPITAL MANAGEMENT, L.L.C. 111,100$9,952,3381.15%
Lisanti Capital Growth, LLC 78,425$7,025,3121.11%
Aristotle Capital Boston, LLC 311,666$27,919,0540.90%
ROYCE & ASSOCIATES LP 947,550$84,881,5290.86%
CHASE INVESTMENT COUNSEL CORP 18,770$1,6810.84%
Virtus Investment Advisers, Inc. 13,662$1,223,8420.83%
View complete list of HAEMONETICS CORP shareholders